文献速递类风湿关节炎

类风湿关节炎滑膜B细胞与临床表型:与疾病阶段及药物暴露的关系

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure.
PubMed 文献 · Arthritis Rheumatol · 2020-03-17

该研究基于两个类风湿关节炎(RA)队列(n=329),包括未治疗早期RA(n=165)和TNF抑制剂应答不足的 established RA(n=164),采用半定量组织学评分评估滑膜CD20+ B细胞浸润,并以数字图像分析和RNA-Seq验证。结果发现B细胞富集型滑膜炎在早期RA占35%、TNFi-IR队列占47.7%(P=0.025),且B细胞富集患者组织学滑膜炎评分在两个队列均显著更高,但早期RA中疾病活动度和血清阳性率更高而 established RA中未见此关联。

要点

  • 半定量CD20评分与数字图像分析和B细胞谱系转录本分析高度一致。
  • B细胞富集型滑膜炎在TNFi-IR的established RA中占47.7%,高于早期RA的35%(P=0.025)。
  • B细胞富集患者组织学滑膜炎评分在早期和established RA中均显著更高。

核心结论

  • 研究描述了一种稳健的半定量组织学B细胞评分,可紧密复现数字或分子分析对B细胞的定量。
  • established RA中B细胞富集型滑膜炎的比例高于早期RA,且可能未被标准临床评估所捕捉。

研究设计与样本

  • 研究纳入两个RA队列共n=329,包括未治疗早期RA(n=165)和TNFi应答不足的established RA(n=164)。
  • 滑膜组织行HE和免疫组化染色,半定量评估滑膜炎(0-9分)和CD20+ B细胞浸润(0-4分),并以数字图像分析和RNA-Seq验证B细胞评分(早期RA n=91,TNFi-IR n=127)。
  • 以半定量CD20评分≥2定义为B细胞富集,<2定义为B细胞贫乏。

主要发现

  • 半定量B细胞评分与数字图像分析定量测量及B细胞谱系特异性转录本相关。
  • B细胞富集型滑膜炎在早期RA队列占35%,在TNFi-IR队列占47.7%(P=0.025)。
  • 早期RA中B细胞富集患者疾病活动度及类风湿因子和抗环瓜氨酸蛋白抗体血清阳性水平更高,但established RA中未见此关联。
  • 两个队列中B细胞富集患者的组织学滑膜炎评分均显著更高。

关键数值与推荐

  • 半定量CD20评分≥2归类为B细胞富集,<2为B细胞贫乏。
  • 滑膜炎半定量评估采用0-9分制,CD20+ B细胞浸润采用0-4分制。

临床怎么用

  • 半定量CD20组织学评分可作为滑膜B细胞浸润的可靠评估工具,与数字图像分析和分子分析结果一致。
  • 在established RA中,即使标准临床评估未提示,仍应关注B细胞富集型滑膜炎的持续存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define the relationship of synovial B cells to clinical phenotypes at different stages of disease evolution and drug exposure in rheumatoid arthritis (RA). METHODS: Synovial biopsy specimens and demographic and clinical data were collected from 2 RA cohorts (n = 329), one of patients with untreated early RA (n = 165) and one of patients with established RA with an inadequate response to tumor necrosis factor inhibitors (TNFi-IR; n = 164). Synovial tissue was subjected to hematoxylin and eosin and immunohistochemical staining and semiquantitative assessment for the degree of synovitis (on a scale of 0-9) and of CD20+ B cell infiltrate (on a scale of 0-4). B cell scores were validated by digital image analysis and B cell lineage-specific transcript analysis (RNA-Seq) in the early RA (n = 91) and TNFi-IR (n = 127) cohorts. Semiquantitative CD20 scores were used to classify patients as B cell rich (≥2) or B cell poor (<2). RESULTS: Semiquantitative B cell scores correlated with digital image analysis quantitative measurements and B cell lineage-specific transcripts. B cell-rich synovitis was present in 35% of patients in the early RA cohort and 47.7% of patients in the TNFi-IR cohort (P = 0.025). B cell-rich patients showed higher levels of disease activity and seropositivity for rheumatoid factor and anti-citrullinated protein antibody in early RA but not in established RA, while significantly higher histologic synovitis scores in B cell-rich patients were demonstrated in both cohorts. CONCLUSION: We describe a robust semiquantitative histologic B cell score that closely replicates the quantification of B cells by digital or molecular analyses. Our findings indicate an ongoing B cell-rich synovitis, which does not seem to be captured by standard clinimetric assessment, in a larger proportion of patients with established RA than early RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rivellese F, Humby F, Bugatti S, et al. B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure. Arthritis Rheumatol. 2020. PMID: 31785084. doi:10.1002/art.41184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。